| Product Code: ETC5360274 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Gastrointestinal Diseases Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Gastrointestinal Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Gastrointestinal Diseases Market - Industry Life Cycle |
3.4 Sweden Gastrointestinal Diseases Market - Porter's Five Forces |
3.5 Sweden Gastrointestinal Diseases Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Sweden Gastrointestinal Diseases Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Sweden Gastrointestinal Diseases Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Sweden Gastrointestinal Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal diseases in Sweden |
4.2.2 Technological advancements in diagnostic and treatment options |
4.2.3 Growing awareness about gastrointestinal health and preventive measures |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of gastrointestinal disease treatments |
4.3.2 High cost associated with advanced diagnostic and treatment procedures |
4.3.3 Limited access to specialized healthcare services in certain regions of Sweden |
5 Sweden Gastrointestinal Diseases Market Trends |
6 Sweden Gastrointestinal Diseases Market Segmentations |
6.1 Sweden Gastrointestinal Diseases Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Antacids, 2021-2031F |
6.1.3 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Laxatives, 2021-2031F |
6.1.4 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Antidiarrheal Agents, 2021-2031F |
6.1.5 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Antiemetics, 2021-2031F |
6.1.6 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Antiulcer Agents, 2021-2031F |
6.1.7 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.2 Sweden Gastrointestinal Diseases Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Oral, 2021-2031F |
6.2.3 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Parenteral, 2021-2031F |
6.2.4 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.3 Sweden Gastrointestinal Diseases Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Ulcerative Colitis, 2021-2031F | 6.3.3 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Irritable Bowel Syndrome, 2021-2031F |
6.3.4 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Crohn Disease, 2021-2031F |
6.3.5 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Celiac Disease, 2021-2031F |
6.3.6 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Gastroenteritis, 2021-2031F |
6.3.7 Sweden Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
7 Sweden Gastrointestinal Diseases Market Import-Export Trade Statistics |
7.1 Sweden Gastrointestinal Diseases Market Export to Major Countries |
7.2 Sweden Gastrointestinal Diseases Market Imports from Major Countries |
8 Sweden Gastrointestinal Diseases Market Key Performance Indicators |
8.1 Patient satisfaction scores with gastrointestinal disease treatment services |
8.2 Adoption rate of new diagnostic technologies in the market |
8.3 Rate of utilization of preventive healthcare services for gastrointestinal diseases |
9 Sweden Gastrointestinal Diseases Market - Opportunity Assessment |
9.1 Sweden Gastrointestinal Diseases Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Sweden Gastrointestinal Diseases Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Sweden Gastrointestinal Diseases Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Sweden Gastrointestinal Diseases Market - Competitive Landscape |
10.1 Sweden Gastrointestinal Diseases Market Revenue Share, By Companies, 2024 |
10.2 Sweden Gastrointestinal Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here